Revision of Applications for Manufacturing and Procurement Quotas
The Drug Enforcement Administration (DEA) proposes to revise existing regulations relating to the management of quotas for schedule I and II controlled substances and the list I chemicals, ephedrine, pseudoephedrine, and phenylpropanolamine, to be utilized by DEA- registered manufacturers. This rule is being proposed t
| Agency | Justice Department, Drug Enforcement Administration |
|---|---|
| Document type | Proposed Rule |
| Published | 2026-05-20 |
| Summary | The Drug Enforcement Administration (DEA) proposes to revise existing regulations relating to the management of quotas for schedule I and II controlled substances and the list I chemicals, ephedrine, pseudoephedrine, and phenylpropanolamine, to be utilized by DEA- registered manufacturers. This rule is being proposed to: restructure DEA's manufacturing and procurement quota regulations for more clarity and consistency; clarify which use-specific subcategories for quotas should be used for controlled substances that will be sold domestically and controlled substances that will be exported; and revise the applications for individual manufacturing and procurement quota. The changes are necessar |
| Document number | 2026-10128 |
| Official record | https://www.federalregister.gov/documents/2026/05/20/2026-10128/revision-of-applications-for-manufacturing-and-procurement-quotas |